Series A - Medherant
Investment Firm
Overview
Medherant is developing a first-in-class transdermal drug delivery patch for prescription and OTC medicines.
Announced Date
May 21, 2019
Funding Type
Series A
Highlights
Location
Europe
Social
Participant Investors
1
| Investor Name |
|---|
Round Details and Background
Medherant raised $2232890 on 2019-05-21 in Series A
Medherant is developing a first-in-class transdermal drug delivery patch for prescription and OTC medicines.
Company Funding History
5
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Oct 03, 2018 |  Grant - Medherant | 1 | - | 67.3K |
| May 21, 2019 | Series A - Medherant | 1 | - | 2.2M |
| Apr 03, 2023 | Venture Round - Medherant | 1 | - | 3.6M |
| Sep 26, 2016 | Seed Round - Medherant | 1 | - | 1.9M |
Recent Activity
There is no recent news or activity for this profile.